2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide

C24H26Cl2N6O3 — CID 11477867

IUPAC2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide
SMILESCc1cnc(NC(=O)Nc2cc(Cl)ccc2OCCCNC(=O)C(N)Cc2ccc(Cl)cc2)cn1
InChIInChI=1S/C24H26Cl2N6O3/c1-15-13-30-22(14-29-15)32-24(34)31-20-12-18(26)7-8-21(20)35-10-2-9-28-23(33)19(27)11-16-3-5-17(25)6-4-16/h3-8,12-14,19H,2,9-11,27H2,1H3,(H,28,33)(H2,30,31,32,34)
InChIKeyWWOANYVMFBUZQE-UHFFFAOYSA-N
MW517.42 g/mol
LogP4.19
Rot. Bonds10

About 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide

2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide (PubChem CID 11477867) has the molecular formula C24H26Cl2N6O3 and a molecular weight of 517.42 g/mol. Its IUPAC name is 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide.

Molecular Properties

Compound Name2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide
PubChem CID11477867
Molecular FormulaC24H26Cl2N6O3
Molecular Weight517.42 g/mol
Exact Mass516.14
IUPAC Name2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide
SMILESCc1cnc(NC(=O)Nc2cc(Cl)ccc2OCCCNC(=O)C(N)Cc2ccc(Cl)cc2)cn1
InChIInChI=1S/C24H26Cl2N6O3/c1-15-13-30-22(14-29-15)32-24(34)31-20-12-18(26)7-8-21(20)35-10-2-9-28-23(33)19(27)11-16-3-5-17(25)6-4-16/h3-8,12-14,19H,2,9-11,27H2,1H3,(H,28,33)(H2,30,31,32,34)
InChIKeyWWOANYVMFBUZQE-UHFFFAOYSA-N
XLogP4.19
TPSA131.26 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500517.42
LogP ≤ 54.19
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide?
The IUPAC name of 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide (CID 11477867) is 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide.
What is the SMILES notation for 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide?
The canonical SMILES for 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide is Cc1cnc(NC(=O)Nc2cc(Cl)ccc2OCCCNC(=O)C(N)Cc2ccc(Cl)cc2)cn1.
What is the InChIKey of 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide?
The InChIKey is WWOANYVMFBUZQE-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26Cl2N6O3/c1-15-13-30-22(14-29-15)32-24(34)31-20-12-18(26)7-8-21(20)35-10-2-9-28-23(33)19(27)11-16-3-5-17(25)6-4-16/h3-8,12-14,19H,2,9-11,27H2,1H3,(H,28,33)(H2,30,31,32,34).
What are the key properties of 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide?
2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide has a molecular weight of 517.42 g/mol, XLogP of 4.19, 10 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-N-[3-[4-chloro-2-[(5-methylpyrazin-2-yl)carbamoylamino]phenoxy]propyl]-3-(4-chlorophenyl)propanamide is sourced from PubChem (CID 11477867), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).